Journal of Vaccines & Vaccination

Self-organization and Effective Cutaneous Vaccination

Qi Wangi^* Department of Dermatology, Harvard Medical School, 50 Blossom Street, Edwards 211, Boston, MA 02114, USA
^*Correspondence: Qi Wangi, Department of Dermatology, Harvard Medical School, 50 Blossom Street, Edwards 211, Boston, MA 02114, USA, Tel: 617-524-7693, Email:

Received: 25-Mar-2020 Published: 17-Apr-2020, DOI: 10.35248/2157-7560.20.11.e414

Editorial

11 years ago the first journal devoted entirely to the publication of research in Journal of Vaccines & Vaccination. There are some journals about the findings of international comparisons show that countries with health system based on strong primary care have better health at lower costs. The journal covers a broad spectrum of topics for study that discusses theoretical and empirical aspects of Vaccines like leadership, management, and administration of public health systems, Human Vaccine Trials, Veterinary Vaccines, Cancer Vaccines, Vaccine Adjutants and hospital networks. The journal solicits manuscripts that discuss technical and medical advancements in Decision Science, Children Vaccines, HIV Vaccine Care Management, Vaccines, Quality and Access. Where we encourage authors to provide insight into their recently published journal.

Journal of Vaccines & Vaccination from a core part of the process of scholarly communication and they also provide a mechanism for the registration of author ’ s precedence, maintaining quality through peer -reviewed and provide a fixed archival version for future reference. The past volumes provide an important way for scientists to navigate the ever-increasing volume of published material. And the development of technology software to address abuses such as plagiarism. The social networks and other social media have yet to make the impact on scholarly communication that they have done on wider consumer web and it become more important for rapid growth in membership of newer scientific social networks.

While many members will continue to serve on the editorial board of the Journal of Vaccines & Vaccination, others have generously chosen to rotate their position to offer other scientists the opportunity to gain experience performing editorial duties.

Upcoming 'Focus on’ the latest and advancements of Vaccines and Vaccination The world is changing, are you ready to read the top Vaccines.

The latest issue of JVV consists of 3 papers. The latest paper, Evaluating the Vaccine Potential of a Tetravalent Fusion Protein against Corona virus (COVID-19) by Mostafa Norizadeh Tazehkand, Orkideh Hajipour presents virus which cause illness ranging from the common cold to other diseases. SARS-CoV-2 is one corona virus family that cause respiratory syndrome. This virus became known as COVID-19. Common signs of infection comprising of fever, respiratory symptoms, cough, shortness of breath and breathing difficulties [1-5].

Our editors consider all forms of diversity when inviting potential reviewers and routinely ask invited reviewers to consider gender balance, ethnic and geographical diversity, and career stage diversity when suggesting alternative reviewers in the event that they must decline our invitation. Despite these efforts, we find that only 26% of our reviewers are women; we are actively working toward increasing this proportion. As part of this effort, we call on our authors to consider diversity when suggesting reviewers for their submitted papers.

Our Editorial Board members are instrumental providing a rapid and efficient editorial process and maintaining high standards within our publication We would like to take this opportunity to thank you for the effort and expertise that you contribute to reviewing, without which it would be impossible to maintain the high standards of double peer-reviewed journals. For the success of any journal, reviewers are an essential part and therefore the reviewers merit sincere appreciation. Journal of Vaccines & Vaccination relies on the efforts and benevolence of the reviewers on assessing the suitability of a manuscript for publication in Journal of Vaccines & Vaccination. The inputs of reviewers are frequently used in improving the quality of a submitted manuscript. The reviewing of a manuscript is very essential to assure the quality of the manuscript published in any journal. I thank all reviewers for their excellent contributions.

Finally, I would like to thank you, the contributors and readers for your interest in the journal and I encourage you to continue to send us your valuable feedback and ideas for further improvement of our journal.

REFERENCES

1. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264-266.
2. Nebehay S, Kelland K, Liu R. WHO: No known effective' treatments for new coronavirus 2020.
3. Ebehay S, Kelland K, Liu R. WHO: No known effective' treatments for new coronavirus. Thomson Reuters 2020.
4. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. The Lancet. 2020
5. Li G, De Clercq E. Therapeutic options for the (2019-nCoV) novel coronavirus 2019.
6. Mishra M. Johnson & Johnson working on vaccine for deadly coronavirus. 2020.